Search Within

Roberta Zappasodi

Formats
  1. Meeting Abstract (35)
  2. Journal Article (28)
  3. Editorial (4)
  4. Review (3)
  5. Guidelines (1)
Groups
  1. Sloan Kettering Institute Postdocs (71)
  2. Department of Medicine (60)
  3. Solid Tumor Oncology Division (58)
  4. Melanoma and Immunotherapeutics Service (56)
  5. GSK Faculty (51)
  6. MSK Grad Students (21)

More Groups

People
  1. Taha Merghoub (55)
  2. Jedd Wolchok (49)
  3. Sadna Budhu (30)
  4. Cailian Liu (19)
  5. Hong Zhong (14)
  6. Levi Mark Mangarin (14)

More People

Years
  1. 2022 (15)
  2. 2021 (9)
  3. 2020 (14)
  4. 2019 (7)
  5. 2018 (10)
  6. 2017 (4)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (24)
  2. Cancer Research (7)
  3. Cancer Immunology Research (4)
  4. Journal of Immunology (4)
  5. Nature (3)
  6. Cancer Cell (2)

More Publications

Publishers
  1. Biomed Central Ltd (24)
  2. American Association for Cancer Research (12)
  3. Nature Publishing Group (8)
  4. Cell Press (5)
  5. The American Association of Immunologists, Inc (4)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (71)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms
    Meeting Abstract

    Gigoux, M.; Elf, S.; Ciboddo, M.; Zappasodi, R.; Pourpe, S.; Abdelfattah, N.; Chan, T.; Abdel-Wahab, O.; Mullally, A.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Rational combination of GITR agonism with PD-1 blockade in cancer patients
    Meeting Abstract

    Zappasodi, R.; Sirard, C.; Li, Y.; Budhu, S.; Abu-Akeel, M.; Liu, C.; Yang, X.; Zhong, H.; Newman, W.; Qi, J.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Strategies for predicting response to checkpoint inhibitors
    Journal Article

    Zappasodi, R.; Wolchok, J. D.; Merghoub, T.
    Current Hematologic Malignancy Reports (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Emerging concepts for immune checkpoint blockade-based combination therapies
    Journal Article

    Zappasodi, R.; Merghoub, T.; Wolchok, J. D.
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • AGEN2034, a novel anti-PD-1 antibody that combines effectively with CTLA-4 pathway blockade to enhance T cell activity
    Meeting Abstract

    Chand, D.; Savitsky, D.; Gonzalez, A.; Clarke, C.; Schuster, A.; Drouin, E. E.; Waight, J. D.; Mundt, C.; Ritter, G.; Merghoub, T.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Phosphatidylserine targeting antibody in combination with tumor radiation and immune checkpoint blockade promotes anti-tumor activity in mouse B16 melanoma
    Meeting Abstract

    Budhu, S.; Giese, R.; De Henau, O.; Zappasodi, R.; Campesato, L. F.; Gupta, A.; Barker, C.; Freimark, B.; Wolchok, J. D.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Identification of unique neoantigen qualities in long-term pancreatic cancer survivors
    Meeting Abstract

    Balachandran, V.; Luksza, M.; Zhao, J. N.; Makarov, V.; Moral, J. A.; Remark, R.; Herbst, B.; Askan, G.; Bhanot, U.; Senbabaoglu, Y.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save
  • Opposing effects of CTLA-4 and PD-1 blockade on follicular helperlike T cells with immunosuppressive functions
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M.; Senbabaoglu, Y.; Gasmi, B.; Zhong, H.; Li, Y.; Liu, C.; Hirschhorhn-Cymerman, D.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save